IL36RN Human, His

Interleukin-36 Receptor Antagonist Human Recombinant, His Tag
Cat. No.
BT16731
Source
Escherichia Coli.
Synonyms
Interleukin 36 receptor antagonist, FIL1, FIL1(DELTA), FIL1D, IL1F5, IL1HY1, IL1L1, IL1RP3, IL36RA, PSORP, FIL1 delta, Interleukin-1 HY1, IL-1 delta, Interleukin-1 receptor antagonist homolog 1, Interleukin-1-like protein 1, UNQ1896/PRO4342.
Appearance
Sterile filtered colorless solution.
Purity
Greater than 95% as determined by SDS-PAGE.
Usage

THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.

Shipped with Ice Packs
In Stock

Description

IL36RN Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 175 amino acids (1-155 a.a) and having a molecular mass of 19.1kDa.
IL36RN is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
Human interleukin family 1, member 5 (IL-1F5 / FIL1-delta) is a cytokine that belongs to the interleukin 1 family. It is expressed by various cells, including monocytes, B cells, dendritic cells/Langerhans cells, keratinocytes, and gastric fundus Parietal and Chief cells. IL1F5 acts as an antagonist of IL1F9, but its mechanism of action regarding receptor binding remains unclear. Notably, human and mouse IL1F5 share a high degree of amino acid sequence identity (90%).
Description
Recombinant human IL36RN, expressed in E. coli, is a single, non-glycosylated polypeptide chain comprising 175 amino acids (1-155 a.a.). It has a molecular mass of 19.1 kDa. The protein includes a 20 amino acid His-tag at the N-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
The IL36RN protein solution is provided at a concentration of 0.5 mg/ml. It is prepared in phosphate-buffered saline (pH 7.4) containing 10% glycerol.
Stability
For short-term storage (2-4 weeks), keep the vial refrigerated at 4°C. For extended storage, freeze the product at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. To maintain product integrity, avoid repeated freeze-thaw cycles.
Purity
The purity of the IL36RN protein is greater than 95%, as determined by SDS-PAGE analysis.
Synonyms
Interleukin 36 receptor antagonist, FIL1, FIL1(DELTA), FIL1D, IL1F5, IL1HY1, IL1L1, IL1RP3, IL36RA, PSORP, FIL1 delta, Interleukin-1 HY1, IL-1 delta, Interleukin-1 receptor antagonist homolog 1, Interleukin-1-like protein 1, UNQ1896/PRO4342.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MVLSGALCFR MKDSALKVLY LHNNQLLAGG LHAGKVIKGE EISVVPNRWL DASLSPVILG VQGGSQCLSC GVGQEPTLTL EPVNIMELYL GAKESKSFTF YRRDMGLTSS FESAAYPGWF LCTVPEADQP VRLTQLPENG GWNAPITDFY FQQCD.

Product Science Overview

Introduction

Interleukin-36 Receptor Antagonist (IL-36Ra) is a member of the interleukin-36 family of cytokines, which also includes three agonists: interleukin-36 alpha, interleukin-36 beta, and interleukin-36 gamma. These cytokines are part of the larger interleukin-1 superfamily . The primary function of IL-36Ra is to inhibit the pro-inflammatory effects of the interleukin-36 cytokines by competing with their receptor, interleukin-36 receptor (IL-36R), thereby preventing the recruitment of the accessory protein interleukin-1 receptor accessory protein (IL-1RAcP) .

Structure and Function

IL-36Ra is a protein coding gene known as IL36RN. It is expressed in various tissues, including the skin, lungs, intestines, joints, and brain . The receptor activation follows a two-step mechanism: the agonist first binds to IL-36R, forming a binary complex that recruits IL-1RAcP. This assembled ternary complex brings together intracellular Toll/Interleukin-1 receptor (TIR) domains of receptors, which activate downstream nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and mitogen-activated protein kinase (MAPK) signaling .

Role in Disease

Mutations in the IL36RN gene can lead to a decrease or production of defective IL-36Ra protein, which has been associated with several inflammatory skin diseases, including generalized pustular psoriasis, acrodermatitis continua suppurativa Hallopeau, and acute generalized exanthematous pustulosis . Dysregulation of IL-36Ra can stimulate keratinocyte and immune cells, enhancing the T-helper 17/T-helper 23 axis and inducing psoriatic-like skin disorders .

Recombinant IL-36Ra

Recombinant IL-36Ra, particularly the human recombinant form with a His tag, is produced using recombinant DNA technology. The His tag is a sequence of histidine residues added to the protein to facilitate purification through affinity chromatography. This recombinant form is used in research to study the protein’s function, signaling pathways, and potential therapeutic applications.

Therapeutic Potential

IL-36Ra has shown promise in therapeutic applications, particularly in treating inflammatory skin diseases. Anti-IL-36 antibodies have been found to attenuate skin inflammation in mouse models of psoriasis, illustrating the potential of targeting IL-36 signaling pathways for therapeutic purposes .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.